Search results
Results from the WOW.Com Content Network
Cipla has 34 manufacturing units in 8 locations across India and a presence in over 80 countries. [ 26 ] [ 27 ] Exports accounted for 48% ₹ 4,948 crore (equivalent to ₹ 84 billion or US$970 million in 2023) of its revenue for the 2013–14 fiscal year. [ 28 ]
The Chicago metropolitan area – also known as "Chicagoland" – is the metropolitan area associated with the city of Chicago, Illinois, and its suburbs. [2] With an estimated population of 9.4 million people, [ 3 ] it is the third largest metropolitan area in the United States [ 4 ] and the region most connected to the city through geographic ...
Cipla, India's No.3 generic drugmaker by sales, reported a better-than-expected quarterly profit on Friday, boosted by strength in its key domestic and North American businesses. The results come ...
Qcil's pharmaceutical manufacturing plant is located in Luzira, an industrial area in Nakawa Division in south-eastern Kampala. The plant is approximately 9 kilometres (6 mi), by road, south-east of Kampala's central business district. [7] The coordinates of the plant are 0°18'17.0"N, 32°38'22.0"E (Latitude:0.304723; Longitude:32.639436). [8]
BENGALURU (Reuters) -Indian drugmaker Cipla said on Friday its U.S. unit was recalling six batches of albuterol sulfate inhalation aerosol due to a "container defect". "The company is initiating a ...
The company posted an 18.3% rise in consolidated net profit to 11.78 billion rupees ($140.8 million) for the quarter ended June 30, surpassing analysts' estimates of 11.10 billion rupees, as per ...
India's revenue from pharmaceutical exports was $25.3 billion in the 2022-2023 financial year. [7] In terms of the global market, India currently holds an accountable share and is known as the pharmacy of the world. [9] The country is the largest global supplier of generic medicine. [10] India produces more than 50% the world's vaccines. [11]
Sun Pharmaceutical Industries Ltd. was established by Dilip Shanghvi in 1983 in Calcutta, West Bengal with five psychiatry products and a two-person marketing team. Today it is ranked number one in share of prescriptions with 12 classes of doctors in India and a market leader in Psychiatry, Neurology, Cardiology, Orthopaedics, Gastroenterology, Nephrology, Diabetology, Dermatology, Urology ...